Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | GABRP | O00591 | 2/20 | 0.33 |
| ▸ | GABRD | O14764 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.33 |
| ▸ | GABRE | P78334 | 2/20 | 0.33 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.33 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.33 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.33 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27327 | 1.00 | — | — | |
| SCHEMBL1773428 | 1.00 | — | — | |
| SCHEMBL757716 | 1.00 | — | — | |
| SCHEMBL9507538 | 0.95 | ALDH1A1 (0.91) | ALDH1A1TSHRMAPK1OPRM1GABRP | |
| Hydrochloric Acid SCHEMBL2260838 | 0.95 | — | — | |
| Water SCHEMBL5799352 | 0.95 | — | — | |
| Ammonia Solution, Strong SCHEMBL9250838 | 0.95 | ALDH1A1 (0.91) | ALDH1A1TSHRMAPK1OPRM1GABRP | |
| SCHEMBL7936337 | 0.95 | — | — | |
| SCHEMBL9324790 | 0.95 | ALDH1A1 (0.91) | ALDH1A1TSHRMAPK1OPRM1GABRP | |
| Hydrazine SCHEMBL9665685 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1083 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2240013-A2 | USE OF A COMPOSITION FOR TREATING THE SURFACES OF LIVESTOCK BUILDINGS AND/OR THE MATERIAL THEREIN | CID LINES N.V. (BE) | 2010-10-20 | — | — | EP | claimed |
| WO-2009098054-A2 | USE OF A COMPOSITION FOR TREATING THE SURFACES OF LIVESTOCK BUILDINGS AND/OR THE MATERIAL THEREIN | CID LINES N.V. (BE) | 2009-08-13 | — | — | WO | claimed |
| US-5188768-A | Solid form electrolyte composites | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1993-02-23 | — | — | US | claimed |
| US-12030865-B2 | Pesticidal mixtures comprising indazoles | FMC CORPORATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240215577-A1 | FUNGICIDAL PYRIDONES | FMC CORPORATION | 2024-07-04 | — | — | US | disclosed |
| CN-118265704-A | Protoporphyrinogen oxidase inhibitors | 恩科化学公司 | 2024-06-28 | — | — | CN | disclosed |
| WO-2024137629-A1 | AZOLE COMPOUNDS FOR CONTROLLING AND COMBATING INVERTEBRATE PESTS | FMC CORPORATION (US) | 2024-06-27 | — | — | WO | disclosed |
| EP-4388876-A2 | FUNGICIDAL NITROANILINO SUBSTITUTED PYRAZOLES | FMC Corporation (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-4387957-A1 | FUNGICIDAL SUBSTITUTED HETEROCYCLES | FMC Corporation (US) | 2024-06-26 | — | — | EP | disclosed |
| CN-112969688-B | Fungicidal nitroaniline-substituted pyrazoles | FMC公司 | 2024-06-04 | — | — | CN | disclosed |
| WO-2024107910-A1 | MIXTURES OF SUCCINATE DEHYDROGENASE INHIBITORS AND PICOLINAMIDES | FMC CORPORATION (US) | 2024-05-23 | — | — | WO | disclosed |
| US-5188768-A | Solid form electrolyte composites | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1993-02-23 | — | — | US | disclosed |
| EP-0513782-A2 | Nitrogen containing surface active agents derived from rosin acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-11-19 | — | — | EP | disclosed |
| EP-0510827-A2 | Silazane polymers and method of making same | THE STANDARD OIL COMPANY (US) | 1992-10-28 | — | — | EP | disclosed |
| US-4939238-A | Nitrogen-containing condensation products based on unmodified or modified natural resins, process for the preparation thereof and the use thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-07-03 | — | — | US | disclosed |
| EP-0341593-A2 | Modified block polymers, their preparation and use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-11-15 | — | — | EP | disclosed |
| EP-0296543-A2 | Condensation products containing nitrogen based on modified or unmodified natural resins, method of making them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-12-28 | — | — | EP | disclosed |
| US-4637985-A | BINDING ASSAY USING A LABELLED CONJUGATE CAPABLE OF EMITTING DELAYED LUMINESCENCE | INTERNATIONALE OCTROOI MAATSCHAPPIJ "OCTROPA" B.V. (NL) | 1987-01-20 | — | — | US | disclosed |
| EP-0044423-B1 | TRIAZOLIDINE-3,5-DIONE SALTS AND THEIR USE IN THE MODIFICATION OR FIRE-RESISTANT FINISHING OF POLYMERS | BAYER AG (DE) | 1983-09-28 | — | — | EP | disclosed |
| EP-0044423-A1 | Triazolidine-3,5-dione salts and their use in the modification or fire-resistant finishing of polymers | BAYER AG (DE) | 1982-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240215577-A1 | FUNGICIDAL PYRIDONES | PNPO, CYP1B1, CYP1A1 | ALDH1A1 676/4885TSHR 3516/4885MAPK1 884/4885 |
| US-12030865-B2 | Pesticidal mixtures comprising indazoles | ACHE, DDT, IDO1 | ALDH1A1 2456/4885TSHR 2835/4885MAPK1 2860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.